Email this article 
Hide
Show all
Evaluation of malaria prevention strategies during pregnancy in Ndola, Zambia
Abstract
Methods: A questionnaire on socio-demographic information, history of malaria during current pregnancy and prevention strategies used was administered to 450 consecutive patients admitted into labour wards at three local clinics. From the antenatal cards, information was collected on the last menstrual period, date of each dose of SP taken, gravidity, and HIV status. A blood slide to detect Plasmodium was then collected from each woman after consent.
Results: Of the participants in the study, 2.4% had a positive blood slide at term and 15.8% reported malaria during pregnancy. All the participants took at least one dose of SP with 87.6% completing the stipulated three doses. The mean gestational ages for each dose were 22.1 (SD 4.6), 29.1 (SD 4.4)and 34.4 (SD 3.9) weeks for the first, second and third dose respectively. With regard to ITNs, 79.5% had one, but only 74.1% used it regularly. IRS was completed in all three of the clinics’ catchment areas. Only 23.4% used commercial insecticide.
Conclusion: The measured prevalence of malaria at term in Ndola was remarkably low, although the self-reported rate during pregnancy was still high. The national targets for accessing IPTp were exceeded, although the timing of each dose needs to be improved. Access to ITNs was high, but usage needs to increase.
How to cite this article:Mulamba M, Mash B. Evaluation of malaria prevention strategies during pregnancy in Ndola, Zambia. Afr J Prm Health Care Fam Med.2010; 2(1), Art. #159,5 pages. DOI: 10.4102/phcfm.v2i1.159
References
World Health Organization. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: WHO Regional Office for Africa; 2004.
Steketee RW, Nahlen BL, Paris ME, Mendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64(1)28-35.
Newman RD, Parise ME, Slutsker L, Nahlen B, Steketee RW. Safety, efficacy, and determinants of effectiveness of antimalarial drugs during pregnancy: Implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health. 2003;8(6):488-506.
Sirima SB, Cotee AH, Konate A, et al. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela district, Burkina Faso. Am J Trop Med Hyg. 2006;75(2):205-211.
Hamer HD, Mwanakasale V, Macleod W, et al. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. J Infect Dis. 2007;196(11):1585-1594.
Van Eijk AM, Ayisi JG, Ter Kuile FO, et al. HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS. 2003;17(4):595-603.
Ter kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with Human Immuno-Deficiency Virus type1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg. 2004;71(suppl 2):41-54.
Idemyor V, Pharm D. Human Immuno-deficiency Virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two titans. HIV Clin Trials. 2007;8(4):246-253.
Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molineux ME. Intermittent sulfadoxine-pyrimethamine in pregnancy: Effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg. 2000;94(5):549-553.
Ramharter M, Schuster K, Bouyou-akotet MK, et al. Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. Am J Trop Med Hyg. 2007;77(3):418-422.
Ministry of Health. National Health Strategic Plan 2006-2010. Lusaka: Ministry of Health; 2005.
Ministry of Health. National scale-up plan for prevention of mother-to-child transmission of HIV and paediatric HIV care services 2007-2010. Lusaka: Directorate of Public Health and Research; 2007.
Ministry of Health. Integrated technical guidelines for frontline health workers. 3rd ed. Lusaka: Ministry of Health; 2009.
Ter Kuile FO, Van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297(23):2603-2616.
Filler SJ, Kazembe P, Thigpen M, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis. 2006;194(3):286-293.
Peters PJ, Thigpen MC, Parise ME, Newman RD. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf. 2007;30(6):481-501.
Challis K, Osman NB, Cotiro M, Nordahl G, Dgedge M, Bergstrom S. Impact of a double dose of sulphadoxine-purimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Trop Med Int Health. 2004;9(10):1066-1073.
Ministry of Health. National Malaria Control Action Plan 2009. Lusaka: Ministry of Health; 2009.
Mkulama MA, Chishimba S, Sikalima J, Rouse P, Thuma PE, Mharakurwa S. Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia. Malar J. 2008;7:87.
McGready R, Tan SO, Ashley EA, et al. Randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. PLoS Medicine. 2008;5(12):253.
Anders K, Marchant T, Chombo P, Mapunda P, Reyburn H. Timing of intermittent preventive treatment for malaria during pregnancy and the implication of current policy on early uptake in north-east Tanzania. Malaria Journal. 2008;7:79-86.
Cottrell G, Mary J, Barro D, Cot M. The importance of the period of malarial infection during pregnancy on birth weight in tropical Africa. Am J Trop Med Hyg. 2000;76(5):849-854.
Ministry of Health. Zambia National Malaria Indicator Survey 2006. Lusaka: Ministry of Health; 2006.
Hill N, Lenglet A, Arnez A, Carneiro I. Plant-based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: Double blind randomised placebo controlled clinical trial in Bolivian Amazon. BMJ. 2007;335(7628):1023.
Full Text: PDF (307) KB HTML XML
